GLP
GLOBAL PARTNERS LP
$48.84
-0.55%
$1.7B
No data for this timeframe.
Vol
Market Cap$1.7B
Cap SizeSmall Cap
Inst. Holders3 funds
Inst. Value$30.7M
Inst. Activity2 buys / 0 sells
Insider Activity17B / 14S
Insider Net $$3.1M
Reddit Sentiment71° Bullish
SEC Reports1
Recent Activity
Jun 8, 2026
SEC
Global GP LLC, the controlling shareholder of Global Partners LP, executed a series of open-market purchases totaling $1
INSIDER-BUY — Impact 6/10
Jun 8, 2026
Insider
Global GP LLC bought 5,000 shares
$49.29 ($246.4K)
Jun 4, 2026
Insider
Global GP LLC bought 5,000 shares
$49.50 ($247.5K)
Jun 3, 2026
Insider
Global GP LLC bought 5,000 shares
$49.42 ($247.1K)
Inst.
UBS Group AG — ADD
235,024 shares ($11.3M)
Inst.
WELLS FARGO & COMPANY/MN — ADD
96,698 shares ($4.6M)
May 8, 2026
earnings_calendar
GLP Q1 2026 Earnings Scheduled — 2026-05-08
Price Targets
Historical data — last covering-analyst action Mar 2026. No current recommendation available.
$45.50 (Mar 2026)
Current $48.22
Low $45.00
Median $45.50
High $46.00
2 analysts
$45.00
$46.00
Analyst Ratings
0Strong Buy
0Buy
4Hold
4Sell
1Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Mar 2, 2026 | Stifel | MAINTAIN | Hold → Hold |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $1.24 ▲ +34.8% | $1.24 — $1.24 | 125% YoY | 1 |
| Next Q | $0.96 ▼ -11.1% | $0.96 — $0.96 | 45% YoY | 1 |
| Current FY | $4.71 ▲ +47.6% | $4.71 — $4.71 | 123% YoY | 1 |
| Next FY | $3.71 ▲ +14.5% | $3.71 — $3.71 | -21% YoY | 1 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| MORGAN STANLEY | $21.5M | TRIM |
| BANK OF AMERICA CORP | $5.2M | — |
| WELLS FARGO & COMPANY/MN | $4.0M | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 8, 2026 | Global GP | BUY | $246.4K |
| Jun 4, 2026 | Global GP | BUY | $247.5K |
| Jun 3, 2026 | Global GP | BUY | $247.1K |
| Jun 2, 2026 | Global GP | BUY | $245.9K |
| Jun 1, 2026 | Global GP | BUY | $242.0K |
Reddit Sentiment
71°
Bullish
Bearish
Neutral
Bullish
3 institutional holders with $30.7M total value (733,138 shares) as of 2025-Q4. Top holders: MORGAN, BANK, WELLS.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 513,420 | $21.5M | 70.0% | TRIM -35.3% |
| 2 | BANK OF AMERICA CORP /DE/ | 123,849 | $5.2M | 16.9% | — |
| 3 | WELLS FARGO & COMPANY/MN | 95,869 | $4.0M | 13.1% | ADD +84.2% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| UBS Group AG | ADD | 185,705 | 235,024 | +26.6% | $11.3M | 2025-Q3 |
| WELLS FARGO & COMPANY/MN | ADD | 52,486 | 96,698 | +84.2% | $4.6M | 2025-Q3 |
| FMR LLC | EXIT | 11,030 | 0 | -100.0% | $0.00 | 2025-Q2 |
| MORGAN STANLEY | TRIM | 631,067 | 408,121 | -35.3% | $21.8M | 2025-Q1 |
| UBS Group AG | ADD | 157,640 | 241,260 | +53.0% | $12.9M | 2025-Q1 |
10 unique insiders with 31 transactions. Net insider value: $3.1M ($4.6M bought, $1.5M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | Global GP LLC | BUY | 5,000 | $49.29 | $246.4K | |
| Jun 4, 2026 | Global GP LLC | BUY | 5,000 | $49.50 | $247.5K | |
| Jun 3, 2026 | Global GP LLC | BUY | 5,000 | $49.42 | $247.1K | |
| Jun 2, 2026 | Global GP LLC | BUY | 5,000 | $49.19 | $245.9K | |
| Jun 1, 2026 | Global GP LLC | BUY | 5,000 | $48.41 | $242.0K | |
| May 29, 2026 | Global GP LLC | BUY | 5,000 | $47.22 | $236.1K | |
| May 28, 2026 | Global GP LLC | BUY | 5,000 | $48.35 | $241.8K | |
| May 27, 2026 | Global GP LLC | BUY | 5,000 | $48.94 | $244.7K | |
| May 26, 2026 | Global GP LLC | BUY | 5,000 | $48.92 | $244.6K | |
| May 22, 2026 | Global GP LLC | BUY | 4,184 | $50.05 | $209.4K | |
| May 21, 2026 | Global GP LLC | BUY | 5,000 | $51.28 | $256.4K | |
| May 20, 2026 | Global GP LLC | BUY | 10,000 | $51.19 | $511.9K | |
| May 19, 2026 | Global GP LLC | BUY | 7,500 | $49.27 | $369.5K | |
| May 18, 2026 | Global GP LLC | BUY | 7,500 | $48.86 | $366.4K | |
| May 15, 2026 | Global GP LLC | BUY | 5,000 | $49.17 | $245.8K | |
| May 14, 2026 | Global GP LLC | BUY | 5,000 | $49.35 | $246.8K | |
| May 13, 2026 | Global GP LLC | BUY | 5,000 | $48.75 | $243.8K | |
| Apr 14, 2026 | Seabrook Kristin K. | Chief Legal Officer & Secy. | M | 3,393 | $0.00 | $0.00 |
| Apr 14, 2026 | Seabrook Kristin K. | Chief Legal Officer & Secy. | F | 1,640 | $45.86 | $75.2K |
| Apr 14, 2026 | Seabrook Kristin K. | Chief Legal Officer & Secy. | M | 3,393 | $0.00 | $0.00 |
| Apr 14, 2026 | Global GP LLC | J | 3,393 | $45.86 | $155.6K | |
| Mar 25, 2026 | Romaine Mark | Chief Operating Officer | SELL | 2,065 | $44.80 | $92.5K |
| Mar 23, 2026 | Romaine Mark | Chief Operating Officer | SELL | 435 | $47.31 | $20.6K |
| Mar 20, 2026 | Romaine Mark | Chief Operating Officer | SELL | 2,020 | $48.19 | $97.3K |
| Mar 19, 2026 | Romaine Mark | Chief Operating Officer | SELL | 3,245 | $48.10 | $156.1K |
| Mar 18, 2026 | Romaine Mark | Chief Operating Officer | SELL | 4,735 | $47.76 | $226.1K |
| Mar 17, 2026 | Romaine Mark | Chief Operating Officer | SELL | 7,500 | $47.39 | $355.4K |
| Mar 16, 2026 | Romaine Mark | Chief Operating Officer | SELL | 3,376 | $47.00 | $158.7K |
| Mar 13, 2026 | Romaine Mark | Chief Operating Officer | SELL | 900 | $47.50 | $42.8K |
| Mar 13, 2026 | Romaine Mark | Chief Operating Officer | SELL | 900 | $47.50 | $42.8K |
| Mar 12, 2026 | Romaine Mark | Chief Operating Officer | SELL | 1,148 | $47.56 | $54.6K |
| Mar 12, 2026 | Romaine Mark | Chief Operating Officer | SELL | 1,323 | $47.62 | $63.0K |
| Mar 11, 2026 | Romaine Mark | Chief Operating Officer | SELL | 1,649 | $48.03 | $79.2K |
| Mar 10, 2026 | Romaine Mark | Chief Operating Officer | SELL | 252 | $48.50 | $12.2K |
| Mar 9, 2026 | Romaine Mark | Chief Operating Officer | SELL | 2,500 | $48.00 | $120.0K |
| Feb 26, 2026 | Kelly Clare McGrory | Director | A | 3,618 | $0.00 | $0.00 |
| Feb 26, 2026 | HAILER JOHN T | Director | A | 3,618 | $0.00 | $0.00 |
| Feb 26, 2026 | OWENS ROBERT W | Director | A | 3,618 | $0.00 | $0.00 |
| Feb 26, 2026 | Romaine Mark | Chief Operating Officer | A | 24,498 | $0.00 | $0.00 |
| Feb 26, 2026 | Slifka Eric | Chairman, President & CEO | A | 66,208 | $0.00 | $0.00 |
| Feb 26, 2026 | Hanson Gregory B. | Chief Financial Officer | A | 19,898 | $0.00 | $0.00 |
| Feb 26, 2026 | Spencer Matthew | Chief Accounting Officer | A | 6,874 | $0.00 | $0.00 |
| Feb 26, 2026 | Pereira Jaime | Director | A | 3,618 | $0.00 | $0.00 |
| Feb 26, 2026 | Seabrook Kristin K. | Chief Legal Officer & Secy. | A | 11,784 | $0.00 | $0.00 |
| Feb 25, 2026 | Romaine Mark | Chief Operating Officer | A | 47,210 | $0.00 | $0.00 |
| Feb 25, 2026 | Slifka Eric | Chairman, President & CEO | A | 128,756 | $0.00 | $0.00 |
| Feb 25, 2026 | Global GP LLC | J | 247,928 | $48.19 | $11.9M | |
| Feb 25, 2026 | Hanson Gregory B. | Chief Financial Officer | A | 32,618 | $0.00 | $0.00 |
| Feb 25, 2026 | Spencer Matthew | Chief Accounting Officer | A | 15,738 | $0.00 | $0.00 |
1 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 0 neutral. Avg impact: 6.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Mar 2026): 0% buy across 9 analysts — 0 strong buy, 0 buy, 4 hold, 4 sell, 1 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Mar 2026. No current recommendation available.
$45.50 mean target (Mar 2026)
$45.00 Low
$46.00 High
| Metric | Value |
|---|---|
| Current Price | $48.22 |
| Target Low | $45.00 |
| Target Mean | $45.50 |
| Target Median | $45.50 |
| Target High | $46.00 |
| # Analysts | 2 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$1.24 | $1.24 | $1.24 | 125.4% | +34.8% | — | $7.5B | 62.2% | 1 |
| Next Q 2026-09-30 |
$0.96 | $0.96 | $0.96 | 45.5% | -11.1% | — | $7.5B | 58.8% | 1 |
| Current FY 2026-12-31 |
$4.71 | $4.71 | $4.71 | 123.2% | +47.6% | 0↑ 1↓ | $28.2B | 52.1% | 1 |
| Next FY 2027-12-31 |
$3.71 | $3.71 | $3.71 | -21.2% | +14.5% | — | $34.4B | 21.7% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $1.240 | |
| 7d ago | $0.920 | +0.320 |
| 30d ago | $0.920 | +0.320 |
| 60d ago | $0.920 | +0.320 |
| 90d ago | $0.900 | +0.340 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Mar 2, 2026 | Stifel | MAINTAIN | Hold | Hold |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 0 | 0 | 4 | 4 | 1 | 0% | |
| May 1, 2026 | 0 | 0 | 4 | 4 | 1 | 0% | |
| Apr 1, 2026 | 0 | 0 | 4 | 4 | 1 | 0% | |
| Mar 1, 2026 | 0 | 0 | 4 | 4 | 1 | 0% | |
| Feb 1, 2026 | 0 | 0 | 4 | 4 | 1 | 0% | |
| Jan 1, 2026 | 0 | 0 | 4 | 4 | 1 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
71°
Bullish
Bearish
Neutral
Bullish
3 mentions
3 bullish
0 bearish
3 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Apr 21, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 21, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Feb 19, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
$LEXX: Why the Most Explosive Chapter in this Company's History is Quietly Baking in the Lab Right Now 🧪🚀
▲ 1
💬 1
⚡ 0.5
Eli Lilly is ready to soar with their latest results get ready for Triple Action GLP's
▲ 1
💬 0
⚡ 0.5
Money printer goes $BRBR
▲ 1
💬 1
⚡ 0.2
The Great Protein Shortage of 2026 coming - DD
▲ 1
💬 0
⚡ 0.2
🟩🎩EMBC - TEVA , Zydus,Sandoz in 🇨🇦
▲ 1
💬 1
⚡ 0.5
✅Analysis of the BofA Healthcare Conference: How Embecta (EMBC) is Changing the Rules in the GLP-1 Market
▲ 1
💬 1
⚡ 0.5
Fractyl Health (GUTS) valuations
▲ 1
💬 1
⚡ 0.5
85% recurring revenue. 5x revenue growth in 5 years. The biotech royalty engine Wall Street forgot.
▲ 1
💬 0
⚡ 0.5
$LEXX: Why a $15M Market Cap for a Proven GLP-1 Platform is a Statistical Absurdity 🚀📈
▲ 1
💬 1
⚡ 0.5
🎩 EMBC-Discrepancies with reality. Stock price anomaly.
▲ 1
💬 1
⚡ 0.1
Stock to watch : FDA reports liver failure in patient taking Eli Lilly’s Foundayo (GLP-1 pill)
▲ 1
💬 1
⚡ 0.5
Thoughts in $MCD
▲ 1
💬 0
⚡ 0.5
May 8, 2026
earnings_calendar
GLP Q1 2026 Earnings Scheduled — 2026-05-08
May 1, 2026
earnings_calendar
GLP Q1 2026 Earnings Scheduled — 2026-05-01
Feb 27, 2026
earnings_calendar
GLP Q4 2025 Earnings Before Market Open — 2026-02-27